y 27632 has been researched along with lipid a in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (lipid a) | Trials (lipid a) | Recent Studies (post-2010) (lipid a) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 3,901 | 125 | 1,143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrhard, M; Fritzsching, B; Frommhold, D; Koch, L; Poeschl, J; Ruef, P | 1 |
1 other study(ies) available for y 27632 and lipid a
Article | Year |
---|---|
Lipid A decreases human erythrocytes deformability by increasing intracellular Ca(2+): effects of verapamil, staurosporine and the rho-kinase inhibitor Y-27632.
Topics: Adult; Amides; Calcium Channel Blockers; Calcium Signaling; Depression, Chemical; Drug Interactions; Erythrocyte Deformability; Escherichia coli; Humans; In Vitro Techniques; Lipid A; Male; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Shear Strength; Staurosporine; Verapamil | 2011 |